- Published half-year turnover down 1.1% to €1,066.4 million, stable on a like for like basis (+ 0.1%) with one fewer business day;
- Net loss attributable to the group of €22.1 million (versus a profit of €24.7 million at the end of December 2016) mainly due to exceptional restructuring charges;
- Decline in reported EBITDA by 11.7% to €103.7 million (down 9.2% on a like-for-like basis) and decrease in the margin rate from 10.9% to 9.7%;
- Deployment of the 2020 strategic plan in line with the objectives to transform, digitalize and restructure the company;
- Net financial debt decreased to €965.2 million at the end of December 2017 (compared with €977.9 million at the end of December 2016).
Despite a more difficult global environment in terms of volumes and ever-increasing pricing constraints, we have managed to maintain our turnover thanks to the diversity of our businesses (Medicine-Surgery-Obstetrics, Post-operative care and Rehabilitation and Mental Health) and by our presence in the heart of heavily populated areas. In addition, we continued to invest heavily in order to strengthen the efficiency of our organizations and to support the digitalization and transformation of our group; this explains the decline in the published EBITDA. These investments are essential if we are to continue to differentiate our business significantly in the sector in the long term.
Pascal Roché, Group Chief Executive Officer
The Board of Directors, meeting on 22 February, approved the consolidated financial statements for the year ended December 2017. The accounts were subject to a limited review by the Statutory Auditors.
| Turnover|| 1 066.4|| -1.1%|| 1 077.8|
|Gross (Operating Surplus) EBITDA||103.7||-11.7%||117.4|
| Current operating profit|| 37.2|| N/A|| 50.2|
| As a % of turnover|| 3.5%|| -1.2 points|| 4.7%|
| Operating profit|| -6.5|| N/A|| 61.0|
| Net income - Group share|| -22.1|| N/A|| 24.7|
| Net earnings per share (in €)|| -0.29|| N/A|| 0.32|
|In € millions - || from 1 July 2017|
to 31 December 2017
|from 1 July 2016|
to 31 December 2016
| Ile de France||438.1||439.5|| -0.3%|
| Auvergne Rhône Alpes||175.1||159.1||+10.1%|
| Nord – Pas de Calais - Picardie||170.6||172.2|| -0.9%|
| Provence Alpes Côte d’Azur||78.3||78.7|| -0.5%|
| Bourgogne Franche Comté||49.5||51.6|| -4.1%|
| Other regions||153.0||149.8|| N/A|
| Other business||1.8||26.9|| -57.0%|
| Published turnover||1 066.4||1 077.8|| -1.1%|
| Of which: - Organic||1 053.8||1 052.3|| 0.1%|
| Of which organic within France||1 042.6||1 041.4|| 0.1%|
| Of which organic within Italy|| 11.2||10.9|| 2.8%|
| - Changes in scope of consolidation||12.6||25.5||-50.6%|
Operations and turnover:
The Group's consolidated turnover for the six-month period ended December 2017 amounted to €1,066.4 million, compared with €1,077.8 million from 1 July 2016 to 31 December 2016. The fall of 1.1% was due to the exit from consolidation scope of the Etang de Berre and Sévigné clinics in 2016, the Herbert clinic in 2017, and despite the entry of the Private Hospital of East Lyonnais in 2017.
On a like-for-like basis, turnover nevertheless increased by 0.1%, despite one fewer business day.
At the end of December 2017, total activity (excluding emergencies) increased by 1.2% in volume. The breakdown by business segment is as follows:
- +1.0% in Medicine-Surgery-Obstetrics
- +1.0% sub-acute care and rehabilitation
- +3.8% in mental health
With regard to the public service tasks managed by the group, the number of emergencies increased strongly, up 6.5% over the past year with 280,000 cases registered by the emergency services of our facilities.
EBITDA for the half-year was €103.7 million, down 11.7% on a reported basis. At constant scope and accounting methods, EBITDA was down 9.2% over the period. The EBITDA margin, as a percentage of turnover, decreased from 10.9% to 9.7%.
Current operating profit for the period 1 July 2017 to 31 December 2017 was €37.2 million (or 3.5% of turnover), down 25.9% from the €50.2 million recorded for the period 1 July 2016 to 31 December 2016.
The other non-current income and expenses resulted in a net expense of €43.7 million for the year ended, consisting almost entirely of restructuring costs. From 1 July 2016 to 31 December 2016, other non-current income and expenses represented a net income of €10.8 million.
The cost of net financial debt amounted to €20.2 million for the six months ended 31 December 2017, compared with €20.5 million the previous year. This consists primarily of interest on senior debt.
In total, the Ramsay Générale de Santé Group recorded a net loss of €22.1 million at the end of December 2017, compared with a profit of €24.7 million for the period from 1 July 2016 to 31 December 2016.
Net financial debt at 31 December 2017 decreased to €965.2 million compared to €977.9 million at 31 December 2016. This debt includes, in particular, €1,099.7 million in non-current borrowings and financial debt, €91.3 million in current financial debt and €180.3 million in cash.
ISIN and Euronext Paris code: FR0000044471
A CONFERENCE CALL IN ENGLISH WILL BE HELD TODAY
at 7.30 p.m. (Paris time) - Dial-in at the following numbers
In France: +33 (0)1 76 77 22 61
In the UK: +44 (0)330 336 6025
In Australia: +61 (0)2 8524 5352
Access code: 465602